Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA)

NCT01352858 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: TolDC
DRUG: Arthroscopy & saline irrigation alone

Sponsor

Newcastle University

Collaborators

[object Object]
[object Object]